| Literature DB >> 23727220 |
Nanette Messemer1, Christin Kunert, Marcus Grohmann, Helga Sobottka, Karen Nieber, Herbert Zimmermann, Heike Franke, Wolfgang Nörenberg, Isabelle Straub, Michael Schaefer, Thomas Riedel, Peter Illes, Patrizia Rubini.
Abstract
Neurogenesis requires the balance between the proliferation of newly formed progenitor cells and subsequent death of surplus cells. RT-PCR and immunocytochemistry demonstrated the presence of P2X7 receptor mRNA and immunoreactivity in cultured neural progenitor cells (NPCs) prepared from the adult mouse subventricular zone (SVZ). Whole-cell patch-clamp recordings showed a marked potentiation of the inward current responses both to ATP and the prototypic P2X7 receptor agonist dibenzoyl-ATP (Bz-ATP) at low Ca(2+) and zero Mg(2+) concentrations in the bath medium. The Bz-ATP-induced currents reversed their polarity near 0 mV; in NPCs prepared from P2X7(-/-) mice, Bz-ATP failed to elicit membrane currents. The general P2X/P2Y receptor antagonist PPADS and the P2X7 selective antagonists Brilliant Blue G and A-438079 strongly depressed the effect of Bz-ATP. Long-lasting application of Bz-ATP induced an initial current, which slowly increased to a steady-state response. In combination with the determination of YO-PRO uptake, these experiments suggest the dilation of a receptor-channel and/or the recruitment of a dye-uptake pathway. Ca(2+)-imaging by means of Fura-2 revealed that in a Mg(2+)-deficient bath medium Bz-ATP causes [Ca(2+)](i) transients fully depending on the presence of external Ca(2+). The MTT test indicated a concentration-dependent decrease in cell viability by Bz-ATP treatment. Correspondingly, Bz-ATP led to an increase in active caspase 3 immunoreactivity, indicating a P2X7-controlled apoptosis. In acute SVZ brain slices of transgenic Tg(nestin/EGFP) mice, patch-clamp recordings identified P2X7 receptors at NPCs with pharmacological properties identical to those of their cultured counterparts. We suggest that the apoptotic/necrotic P2X7 receptors at NPCs may be of particular relevance during pathological conditions which lead to increased ATP release and thus could counterbalance the ensuing excessive cell proliferation.Entities:
Keywords: 2-MeSATP; 2-methylthio ATP; 2′(3′)-O-(4-benzoylbenzoyl)adenosine-5′-triphosphate; 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate; 3-(4,5-dimethylthioazol-2-yl)-2,5-diphenyltetrazoliumbromid; 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one; 5-BDBD; Adult neural progenitor cells; BBG; Brain subventricular zone; Brilliant Blue G; Bz-ATP; CNS; E(max); EC(50); EGF; Extracellular ATP; FGF-2; GAPDH; GFAP; MTT; Msi1; NPC; P2X7 receptors; PPADS; SVZ; TNP-ATP; X(2) concentration; [Ca(2+)](i); central nervous system; concentration of agonist producing 50% of E(max); divalent cation concentration; epidermal growth factor; fibroblast growth factor-2; glial fibrillary acidic protein; glyceraldehyde 3-phosphate dehydrogenase; intracellular Ca(2+) concentration; maximal effect; musashi1; neural progenitor cell; pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid; subventricular zone; wild-type; wt; α,β-meATP; α,β-methylene ATP
Mesh:
Substances:
Year: 2013 PMID: 23727220 DOI: 10.1016/j.neuropharm.2013.05.017
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250